The group hopes its proposed regulatory framework might strike a compromise between different industry stakeholders.

Despite the findings of the Hopkins study, for practical and economic reasons many diagnostic laboratories currently only sequence tumor samples or do not believe the tumor-normal approach is necessary.

lemon tree, Madrid

Researchers delved into citrus relationships and history with newly sequenced chloroplast genomes for 30 citrus plants and existing whole genomes for four more.

Sequencing on samples from individuals in a previously uncontacted Venezuelan tribe pointed to extraordinarily diverse gut and skin microbiomes.

A new genome-wide association study used imputation to test millions of variants in basal cell carcinoma cases and controls from Iceland.

Recently introduced legislation would allow employers to ask people about their family medical history as part of financially incentivized wellness programs.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease. 

Grace Bio-Labs has developed the ArrayCAM Microarray System, a complete protein microarray analytical solution comprised of high protein- binding porous nitrocellulose (PNC), multi-color quantum nanocrystal detection labels, rapid image acquisition instrumentation including automated software analysis to overcome typical challenges associated with the precise study of cell signaling pathways such as sensitivity for detection of low abundance proteins and consistent data normalization.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.